SCHEMBL23869124

SCHEMBL23869124

c1ccc(-c2nc(-c3ccc(-c4ccc5ccccc5c4)cc3)nc(-c3ccc4c(c3)[Si](c3ccccc3)(c3ccccc3)c3ccccc3-4)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36
CYP17A1 P05093 1/20 0.36
CYP19A1 P11511 1/20 0.36
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23869233 1.00 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL23869072 0.97 MEN1 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22947283 0.97 MEN1 (0.41) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL23868753 0.92 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL23869125 0.92 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL23868950 0.92 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949684 0.92 MEN1 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949327 0.92 MEN1 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949535 0.92 MEN1 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22572812 0.92 MEN1 (0.39) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210300951-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300951-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 MEN1 2890/4885KMT2A 3846/4885ALDH1A1 201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.